AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 97 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $454,000 | -13.2% | 16,880 | +2.8% | 0.07% | -15.4% |
| Q1 2018 | $523,000 | -15.8% | 16,420 | 0.0% | 0.08% | -16.1% |
| Q4 2017 | $621,000 | +119.4% | 16,420 | +43.8% | 0.09% | +102.2% |
| Q3 2017 | $283,000 | +28.6% | 11,420 | +6.7% | 0.05% | +21.1% |
| Q2 2017 | $220,000 | -51.1% | 10,700 | -48.3% | 0.04% | -51.9% |
| Q1 2017 | $450,000 | – | 20,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |